AKTX vs GILD: Which Stock is Better?
Side-by-side comparison of Akari Therapeutics Plc and Gilead Sciences Inc in 2026
AKTX
Akari Therapeutics Plc
$0.16
GILD
Gilead Sciences Inc
$141.29
Key Metrics Comparison
| Metric | AKTX | GILD | Winner |
|---|---|---|---|
| Market Cap | $16.96M | $179.26B | GILD |
| P/E Ratio | N/A | 21.27 | GILD |
| EPS (TTM) | $N/A | $6.79 | GILD |
| Revenue Growth | 0.0% | 0.0% | GILD |
| Gross Margin | 0.0% | 78.8% | GILD |
Analyze AKTX
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is AKTX or GILD a better investment?
Comparing AKTX and GILD: Akari Therapeutics Plc has a market cap of $16.96M while Gilead Sciences Inc has $179.26B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between AKTX and GILD?
AKTX (Akari Therapeutics Plc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: AKTX or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: AKTX or GILD?
GILD has higher revenue growth at 0.0% vs 0.0% for AKTX.
Which company is more profitable: AKTX or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 0.0% for AKTX.
Which is the larger company: AKTX or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $179.26B compared to $16.96M for AKTX.
Should I buy AKTX or GILD in 2026?
Both AKTX and GILD have investment merit. AKTX trades at $0.16 while GILD trades at $141.29. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between AKTX and GILD stock?
Key differences: Market Cap ($16.96M vs $179.26B), P/E Ratio (N/A vs 21.3x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 78.8%).